AKUMS
Invest Now

Akums Drugs & Pharmaceuticals Share Price
₹473.20 +12.95 (2.81%)
29 Mar, 2025 04:09
Start SIP in
AKUMS
Performance
- Low
- ₹463
- High
- ₹480
- 52 Week Low
- ₹433
- 52 Week High
- ₹1,176
- Open Price₹465
- Previous Close₹460
- Volume345,942
Investment Returns
- Over 1 Month -0.04%
- Over 3 Month -29.2%
- Over 6 Month -43.17%
- Over 1 Year -30.31%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 49.9
- PEG Ratio
- -
- Market Cap Cr
- 7,448
- P/B Ratio
- 2.6
- Average True Range
- 24.95
- EPS
- 9.08
- Dividend Yield
- 0
- MACD Signal
- -12.92
- RSI
- 40.2
- MFI
- 24.42
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹473.20
+
12.95
(2.81%)

-
- Bearish Moving Average 13
-
- Bullish Moving Average 1
- 20 Day
- ₹493.55
- 50 Day
- ₹528.53
- 100 Day
- ₹603.57
- 200 Day
- -
Resistance and Support
472.1
- R3 498.00
- R2 489.00
- R1 481.10
- S1 464.20
- S2 455.20
- S3 447.30
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-06 | Quarterly Results | |
2024-11-09 | Quarterly Results | |
2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹473 As on 29 March, 2025 | 03:55
The Market Cap of Akums Drugs & Pharmaceuticals is ₹7447.9 Cr As on 29 March, 2025 | 03:55
The P/E ratio of Akums Drugs & Pharmaceuticals is 49.9 As on 29 March, 2025 | 03:55
The PB ratio of Akums Drugs & Pharmaceuticals is 2.6 As on 29 March, 2025 | 03:55
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.